Geosearch / Live Stats / Bug Report / FAQ / About LinkedCT

Eligibility: 64dbc86c5acbfd7bdc2684ba98ae43c1 [RDF]

Label 64dbc86c5acbfd7bdc2684ba98ae43c1
Slug 64dbc86c5acbfd7bdc2684ba98ae43c1
Criteria DISEASE CHARACTERISTICS: Histologically diagnosed stage II or III multiple myeloma Stage I multiple myeloma progressing on conventional therapy HLA matched donor Related - ages 18-65 Unrelated - ages 18-55 PATIENT CHARACTERISTICS: Age: 18 to 65 Performance status: Karnofsky 70-100% Life expectancy: Not specified Hematopoietic: Not specified Hepatic: No significant hepatic disease Bilirubin no greater than 2 mg/dL Renal: Creatinine clearance at least 40 mL/min Calcium no greater than 15 mg/dL Cardiovascular: No significant cardiac disease Ejection fraction at least 40% Pulmonary: No significant pulmonary disease FEV1 at least 50% OR DLCO at least 50% Other: No obesity Chest wall no greater than 3 cm thick No pendulous breasts HIV negative PRIOR CONCURRENT THERAPY: Must have received prior conventional therapy for stage I disease
Maximum age 65 Years
Healthy volunteers No
Study pop
Minimum age 18 Years
Gender Both
Sampling method
Provenances http://clinicaltrials.gov/show/NCT00003195?displayxml=true
Similars None
Interlinks None